Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2025Gastric CancerOpen Access

Angiotensin receptor blocker and angiotensin-converting enzyme inhibitor use and survival in gastric cancer patients: a Finnish nationwide cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

AAA. AuvinenPAPanu AaltonenHMHarri Mustonen

Discussion

Loading...

Member takes

Overview

Retrospective cohort study reveals angiotensin receptor blockers improve survival rates in gastric cancer, suggesting potential therapeutic benefits.

Key Points

  • ARB use significantly reduced overall mortality in gastric cancer patients, highlighting a potential treatment benefit.
  • Patients using higher dosages of ARBs exhibited greater survival improvements compared to those on ACEIs.
  • This retrospective national cohort study analyzed data from over 2246 gastric cancer patients diagnosed from 2011 to 2016.
  • Findings suggest ARBs may enhance survival in gastric cancer patients, supporting further investigation into their therapeutic role.

Cite This Study

Auvinen et al. (2025) studied this question.

synapsesocial.com/papers/68d43c8e713b0b5dfea7c7e3https://doi.org/10.1007/s10120-025-01662-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data2005 · 10,820 citations